Skip to main content
Menu

Nucleic acid extraction in biobanking

Scalable, automated DNA/RNA extraction for long-term research

Biobanks today are under increasing pressure to process diverse sample types at unpredictable volumes. Those performing extractions must deliver high-quality nucleic acids that meet the criteria of all downstream and future assays, even after years of storage.

Revvity has a global footprint in biobanking and has supported numerous population cohort studies involving millions of samples. With automation expertise, chemagic™ separation technology and proprietary M-PVA Magnetic Bead chemistry, Revvity has been a trusted partner - helping biobanks streamline operations, maximize sample value and accelerate scientific discovery with confidence.


For research use only. Not for use in diagnostic procedures.

nucleic acid extraction in biobanking

chemagic technology - used by biobanks globally

Benefits of chemagic technology in biobanking:

  • High yields of high integrity, ultrapure nucleic acids with proven performance in challenging downstream assays including Long Read Sequencing, NGS, dPCR, MLPA and more.
  • Archival quality of nucleic acids and compatibility with diverse sample material of variable quality stored over many years.
  • Single supplier solution (of both reagents and instrumentation) facilitates efficient implementation of workflow with time-savings from less administrative overhead, optimized performance and efficient technical support.
  • Excellent support from our team of application and automation scientists backed by more than 25 years of experience with diverse field demands.
     

Revvity AI Assistant Beta

Scroll Icon